A National Referral Service for Paediatric Brachytherapy: An Evolving Practice and Outcomes Over 13 Years.


Journal

Clinical oncology (Royal College of Radiologists (Great Britain))
ISSN: 1433-2981
Titre abrégé: Clin Oncol (R Coll Radiol)
Pays: England
ID NLM: 9002902

Informations de publication

Date de publication:
04 2023
Historique:
received: 07 11 2022
accepted: 15 12 2022
pubmed: 2 1 2023
medline: 14 3 2023
entrez: 1 1 2023
Statut: ppublish

Résumé

Most children requiring radiotherapy receive external beam treatment and few have tumours suitable for brachytherapy. No paediatric radiotherapy centre will treat enough patients from its own normal catchment population for expertise in brachytherapy to be developed and sustained. Following discussion and agreement in the national paediatric radiotherapy group, a service for paediatric brachytherapy in the UK has been developed. We report the process that has evolved over more than 10 years, with survival and functional outcome results. Since 2009, potential patients have been referred to the central paediatric oncology multidisciplinary team meeting, where imaging, pathology and treatment options are discussed. Since 2013, the National Soft Tissue Sarcoma Advisory Panel has also reviewed most patients, with the principal aim of advising on the most suitable primary tumour management for complex patients. Clinical assessment and examination under anaesthetic with biopsies may be undertaken to confirm the appropriateness of brachytherapy, either alone or following conservative surgery. Fractionated high dose rate brachytherapy was delivered to a computed tomography planned volume after implantation of catheters under ultrasound imaging guidance. Since 2019, follow-up has been in a dedicated multidisciplinary clinic. From 2009 to 2021 inclusive, 35 patients (16 female, 19 male, aged 8 months to 17 years 6 months) have been treated. Histology was soft-tissue sarcoma in 33 patients and carcinoma in two. The treated site was pelvic in 31 patients and head and neck in four. With a median follow-up of 5 years, the local control and overall survival rates are 100%. Complications have been few, and functional outcome is good. Brachytherapy is effective for selected paediatric patients, resulting in excellent tumour control and good functional results. It is feasible to deliver paediatric brachytherapy at a single centre within a national referral service.

Identifiants

pubmed: 36588012
pii: S0936-6555(22)00609-4
doi: 10.1016/j.clon.2022.12.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-244

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

M N Gaze (MN)

University College London Hospitals NHS Foundation Trust, London, UK; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. Electronic address: mgaze@nhs.net.

N Smeulders (N)

University College London Hospitals NHS Foundation Trust, London, UK; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

R Ackwerh (R)

University College London Hospitals NHS Foundation Trust, London, UK.

C Allen (C)

University College London Hospitals NHS Foundation Trust, London, UK.

N Bal (N)

University College London Hospitals NHS Foundation Trust, London, UK.

M Boutros (M)

University College London Hospitals NHS Foundation Trust, London, UK.

A Cho (A)

University College London Hospitals NHS Foundation Trust, London, UK; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

G Eminowicz (G)

University College London Hospitals NHS Foundation Trust, London, UK.

E Gill (E)

University College London Hospitals NHS Foundation Trust, London, UK.

M W Fittall (MW)

University College London Hospitals NHS Foundation Trust, London, UK.

P D Humphries (PD)

University College London Hospitals NHS Foundation Trust, London, UK.

P Lim (P)

University College London Hospitals NHS Foundation Trust, London, UK; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

I Mushtaq (I)

Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

T Nguyen (T)

University College London Hospitals NHS Foundation Trust, London, UK.

C Peet (C)

University College London Hospitals NHS Foundation Trust, London, UK.

D Pendse (D)

University College London Hospitals NHS Foundation Trust, London, UK.

S Polhill (S)

University College London Hospitals NHS Foundation Trust, London, UK.

H Rees (H)

University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.

G Sands (G)

University College London Hospitals NHS Foundation Trust, London, UK.

A Shankar (A)

University College London Hospitals NHS Foundation Trust, London, UK.

O Slater (O)

Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

T Sullivan (T)

University College London Hospitals NHS Foundation Trust, London, UK.

P J Hoskin (PJ)

University College London Hospitals NHS Foundation Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH